A project from the American Society of Retina Specialists
Sign in to view content
Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results
- Video
- Published 2019
Jeffrey S. Heier, MD
AMD Non-neovascular Symposium
Related
Category: AMD-Non-Neovascular